WO2016133321A1 - Microparticule pour essai biologique et son procédé de fabrication - Google Patents
Microparticule pour essai biologique et son procédé de fabrication Download PDFInfo
- Publication number
- WO2016133321A1 WO2016133321A1 PCT/KR2016/001493 KR2016001493W WO2016133321A1 WO 2016133321 A1 WO2016133321 A1 WO 2016133321A1 KR 2016001493 W KR2016001493 W KR 2016001493W WO 2016133321 A1 WO2016133321 A1 WO 2016133321A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- encoder pattern
- region
- encoder
- master mold
- bioassay
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title claims abstract description 81
- 238000000034 method Methods 0.000 title claims abstract description 61
- 238000004166 bioassay Methods 0.000 title claims abstract description 56
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 239000000523 sample Substances 0.000 claims abstract description 38
- 230000008569 process Effects 0.000 claims abstract description 31
- 239000000758 substrate Substances 0.000 claims abstract description 22
- 238000000059 patterning Methods 0.000 claims abstract description 15
- 229920005989 resin Polymers 0.000 claims description 29
- 239000011347 resin Substances 0.000 claims description 29
- 229920002120 photoresistant polymer Polymers 0.000 claims description 23
- 239000011148 porous material Substances 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 239000002131 composite material Substances 0.000 claims description 6
- 230000002209 hydrophobic effect Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims 1
- 235000002020 sage Nutrition 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 14
- 230000002068 genetic effect Effects 0.000 abstract description 8
- 238000003753 real-time PCR Methods 0.000 abstract description 7
- 238000011002 quantification Methods 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 19
- 239000000463 material Substances 0.000 description 16
- 238000001514 detection method Methods 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 238000001723 curing Methods 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 7
- 229920001486 SU-8 photoresist Polymers 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- -1 polydimethylsiloxane Polymers 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000007734 materials engineering Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
- B01F33/302—Micromixers the materials to be mixed flowing in the form of droplets
- B01F33/3021—Micromixers the materials to be mixed flowing in the form of droplets the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
Definitions
- the present specification relates to microparticles for a bioassay and a method of manufacturing the same.
- Molecular diagnostic systems are the next generation of convergence technologies across science and technology, including electronics, physics, chemistry, biology, materials engineering, IT, and NT, and are emerging as innovative technologies for the diagnosis and treatment of diseases.
- the biochip which is one of the representative fields of molecular diagnostic systems, attaches high density biomolecule probes such as DNA and proteins onto substrates such as glass, silicon, and polymers, and thus targets in the probes and samples. It detects the hybridization with a substance and is usefully used to analyze a very small amount of sample at a high speed.
- gene information such as gene expression and response patterns, gene defects, and protein distribution can be analyzed to ultimately be used for diagnosis and treatment of human diseases, as well as for new drug development and reagent diagnosis.
- biochips may be divided into DNA chips or protein chips according to the type of probe, and may be divided into microarray chips attached to a solid substrate and microfluidic chips attached to a microfluidic channel according to the attachment form of the probe.
- a fluorescent substance or radioactive material for obtaining a signal that can be directly measured by the researchers can be detected. Labeling materials such as substances and magnetic particles are used.
- One of such multiple analysis techniques is by positional microarrays, and forms genetic probes or code regions specific to X and Y coordinates to analyze genetic information, which is an advantage for ultra high density analysis. have.
- suspension array suspension array
- color coding method by a variety of dyes (fluorescent material) each expressing different emission colors (fluorescent material) a large amount of a large amount of The advantage is that the sample can be processed.
- the planar microarray technique and the color coding scheme have poor reproducibility and are not easy to perform real-time PCR analysis, and thus, it is difficult to accurately recognize and quantify accurate genetic information.
- the detection information on the genetic information is inaccurate due to the interference and perturbation between the detection information according to the detection signal measuring method according to the labeling material, the direction and sensitivity of the detector, and the like. Is lacking.
- multi-analysis technology provides a technique for particle-based diagnosis, and the use of small particles can increase the response surface area to increase responsiveness. There is an advantage that can proceed with various assays.
- Korean Patent Application Publication No. 10-2009-0091117 “Multifunctional Encoded Particles for High Performance Analysis,” flows fluorescently labeled monomers along microfluidic channels, and other adjacent ones. After flowing the probe-lead off monomers along the microfluidic channel, they are polymerized and exposed to the ultraviolet light transmitted through the photomask to form particles having the cord region and the probe region.
- the above method forms particles intermittently retaining the probe region and the code region by the photomask along the microfluidic channel, so that the loss of material between particles generated by the photolithography process along the microfluidic channel is reduced. There is an uneconomic problem.
- the particles produced by the above method is impossible to implement the real-time PCR, there is a disadvantage that cannot accurately quantify and recognize the genetic information.
- the present invention is to solve the above problems, it is possible to manufacture the microparticles for bioassay using the mask patterning process and the spotting and imprinting process, in particular, since the probe region and the encoder region is not separated, real-time PCR application It is an object of the present invention to provide microparticles and methods for their preparation for this possible bioassay.
- an embodiment of the present invention has a flat three-dimensional shape with a flat bottom surface, and a probe region for quantitatively detecting bio-assay information and an encoder pattern formed on the bottom surface.
- a microparticle for a bioassay comprising an encoder region for recognizing a kind of bio-assay information, wherein the probe region and the encoder region are superimposed within a substrate.
- an embodiment of the present invention is to form a photoresist layer on a substrate, a first step of manufacturing a first mold having an embossed encoder pattern made of a photoresist by a mask patterning process, and on the first mold Forming a imprint resin layer and forming a master mold formed of an imprint resin by an imprinting process to form a negative encoder pattern; spotting a solution for bioassay on the negative encoder pattern region formed in the master mold ( spotting to form droplets and curing the droplets formed on the master mold, and then separating them on the master mold to form microparticles having an encoder pattern formed thereon. It provides a method for producing micro particles for a bio assay comprising.
- the manufacturing method according to an embodiment of the present invention uses a mask patterning process, a spotting and an imprinting process, to form microparticles for a bioassay in which a probe region and an encoder region are not separated in the same substrate and overlapped. Can provide.
- the microparticles can be applied to real-time PCR has the effect of accurate quantification and recognition for genetic information analysis.
- the mask patterning process ensures the precision of the encoder pattern (5 ⁇ m or less), and enables encoding of more than 10 9 , enabling detection of various information of ultra-fine samples, spotting only on the negative encoder pattern formed on the master molder. Since the droplets are formed by the process, waste of the probe material can be reduced, thereby reducing the cost.
- Micro particles according to an embodiment of the present invention is formed in a flat bottom surface, the patterned encoder region is formed to always be horizontal to the bottom surface, it is possible to fix the encoder in a certain direction. As a result, the accuracy of the detection information can be guaranteed, and even with a very small amount of sample, high sensitivity can be detected, thereby improving the reproducibility of the experiment.
- one embodiment of the present invention can detect whether or not hybridization with the target material from the contrast and the change in the concentration of the encoder pattern even with a normal CCD camera, regardless of the use of the labeling material, and easy to experiment, There is an effect that can reduce the cost for using the labeling material.
- FIG. 1 is a schematic diagram of a method for preparing microparticles for bioassay according to an embodiment of the present invention.
- Figure 2 is a view showing a side photograph of the droplet formed on the master mold prepared according to an embodiment of the present invention.
- Figure 3 is a view showing a photograph (a), a photograph (b), (c), (d) of the micro-particles for the master mold prepared according to an embodiment of the present invention.
- Figure 4 is a view showing a picture of the microparticles according to one embodiment of the present invention.
- FIG. 6 is a view showing a schematic diagram ((a) cross section, (b) bottom view) of the microparticles constituting the composite structure prepared according to an embodiment of the present invention.
- the present invention relates to microparticles for multiplexing bioassays that can reduce analysis time and obtain a variety of information at low cost by simultaneously quantifying and recognizing bioassays, particularly DNA, RNA, proteins and the like.
- the present invention aims to provide microparticles for a bioassay in which a probe region and an encoder region are not separated in the same substrate and overlapped using a mask patterning process and an imprinting process.
- microparticles for bioassay in a significantly simpler method than the prior art.
- the probe region and the encoder region are not separated, real-time PCR can be applied, and thus there is an advantage in that accurate quantification and recognition for genetic information analysis is possible.
- Figure 1 shows a schematic diagram of a method for producing microparticles for bioassay according to an embodiment of the present invention.
- Figure 2 shows a side photograph of the droplet formed on the master mold prepared according to an embodiment of the present invention.
- Figure 3 shows a photograph (a) for the master mold prepared in accordance with an embodiment of the present invention, a photograph (b) for the droplets, a photograph (c), (d) for the microparticles.
- 4 is a photograph of microparticles according to various embodiments of the present disclosure.
- FIG. 5 shows a BF image (a) after PCR, a fluorescence image (b) before and after PCR for microparticles according to an embodiment of the present invention.
- Figure 6 shows a schematic diagram ((a) cross-sectional view, (b) bottom view) of the microparticles constituting the composite structure prepared according to an embodiment of the present invention.
- a photoresist layer is formed on a substrate, and an embossed encoder pattern made of the photoresist is formed by a mask patterning process.
- a first step of manufacturing the formed first mold A second step of forming an imprint resin layer on the first mold and fabricating a master mold having imprint resin patterns formed of imprint resin by an imprinting process;
- the microparticles are used in a device for detecting and analyzing a target nucleic acid in a bioassay, and the micro size of nano ( 10-6 ), micro ( 10-3 ), millimeter ( 10-2 ), etc.
- the concept includes all of the particles.
- the microparticle includes a probe region for quantitatively detecting information about a target nucleic acid or a fixed primer reacting with the target nucleic acid, ie, bioassay information, and an encoder region for recognizing a kind thereof.
- the present invention has a flat three-dimensional shape with a flat bottom surface, and the bio-assay is formed by a probe region for quantitatively detecting bio-assay information and an encoder pattern formed on the bottom surface.
- assay may include a microparticle for a bioassay, comprising an encoder region for recognizing a kind of information, wherein the probe region and the encoder region overlap each other in a substrate.
- microparticles may be hemispherical or semi-elliptic.
- an opaque metal layer or an array of photoresist layers may be formed on the encoder pattern of the microparticles.
- the microparticle may further include a probe region or an encoder region of another kind, to form a complex structure.
- microparticles according to an embodiment may further include pores in the particles.
- a photoresist layer is formed on a substrate and a first mold having an embossed encoder pattern made of a photoresist is formed by a mask patterning process. It may include (step 1, (a)).
- the substrate may be any flat substrate such as metal, silicon, glass, and polymer, and the area of the substrate may be adjusted according to the size and number of encoder patterns to be formed.
- the photoresist layer may be coated on the substrate to form an encoder pattern, and the thickness of the photoresist layer may be adjusted in consideration of the size of the recess of the encoder pattern.
- the photoresist layer may be any resin as long as it is a resin that can be used in a mask patterning process by photolithography.
- a radiation curable epoxy acrylate, urethane acrylate, polyester acrylate, and a substituent having a refractive index adjusted may be used. More specific examples may use SU-6, SU-7, SU-8, and the like.
- the photoresist layer is formed on a substrate, and then selectively exposed using a mask on which an encoder pattern is drawn in advance, and then a portion of the photoresist that is not cured by the exposure process is removed through a developing process, and the cured Only the photoresist may form an embossed encoder pattern.
- the embossed encoder pattern means a pattern corresponding to the final encoder pattern. Since the final encoder pattern is formed by the master mold to be described later, the one having the opposite image is referred to as an embossed encoder pattern.
- the first mold having the embossed encoder pattern made of the photoresist manufactured by the mask patterning process is guaranteed with precision (5 ⁇ m or less) of the encoder pattern, and capable of encoding more than 10 9 .
- precision 5 ⁇ m or less
- An embodiment of the present invention may include forming an imprint resin layer on the first mold, and manufacturing a master mold formed of an imprint resin by an imprinting process to form a negative encoder pattern (second step, ( b) step).
- the imprint resin layer may be imprinted on the first mold and compressed by using a roller or the like so that the negative encoder pattern of the first mold is imprinted on the imprint resin layer.
- the imprint resin layer may be photocured to fix the pattern made of the imprint resin.
- a master mold including the imprint resin is formed to form an engraved encoder pattern (a pattern corresponding to the embossed encoder pattern of the first mold).
- a photocurable resin may be used for the imprint resin layer.
- the photocurable resin used in the imprint resin layer may be the same as the resin used in the photosensitive resin layer, or may be a pre-polymer in which a polydimethylsiloxane (PDMS) solution and a curing agent are mixed.
- PDMS polydimethylsiloxane
- the method may further include: hydrophilizing a surface of a negative encoder pattern region in the master mold after the second step; Alternatively, the method may further include hydrophobic treatment of the surface of the region except the negative encoder pattern region in the master mold.
- the hydrophilic treatment is performed on the negative encoder pattern region or the non-spotted negative encoder pattern region is formed by spotting a bioassay solution to be described later when the hydrophobic treatment is performed. It is possible to set it correctly. In this case, droplets can be easily formed without using a spotting device.
- the hydrophilic treatment may include an oxide layer including at least one of oxide-based materials such as SOG, TEOS, LTO, silicon oxide, titanium oxide, and aluminum oxide using a mask on the negative encoder pattern region. It may be.
- the hydrophobic treatment may be implemented by any one of deposition of hydrophobic material, coating of hydrophobic material, silanizing treatment, and plasma treatment using a mask in a region other than the negative encoder pattern region. .
- an embodiment of the present invention may include spotting a solution for bioassay on a negative encoder pattern formed in the master mold to form droplets (step 3, (c )step).
- droplets may be formed by spotting the bioassay solution only on a region where the negative encoder pattern is formed in the master mold, thereby reducing waste of the bioassay solution (ie, probe material).
- the bioassay solution may be used without limitation as long as it is formed of a transparent material capable of reading an encoder pattern from the outside.
- the polymer may include one or more polymers of polyethylene glycol-diacrylate (PEG-DA), polyacrylamide (PA), and agarose.
- the bioassay solution may be a polymerase chain reaction (PCR) primer other than the polymer, a cyanine-based dye that provides quantitative information of a nucleic acid that is amplified by complementarily binding to a target nucleic acid, EtBr. , TaqMan TM It may further include a fluorescent marker, such as a probe, oligo-nucleotide probe (Molecular Beacon probe) and the like.
- PCR polymerase chain reaction
- the bioassay solution may act as a matrix of the microparticles according to the present invention to change the type of the substrate itself or to form primers or probes included in the substrate. This makes it possible to detect information on the kind, size or amount of different kinds of target nucleic acids or immobilized primers reacting with them at the same time.
- the bottom surface may have a flat three-dimensional shape. Specifically, it may be hemispherical or semi-elliptic.
- the spotting may use a spotting device capable of fine control with a solenoid valve or the like, and may control the size of the droplet by controlling the spotting time and flow rate.
- an embodiment of the present invention may include curing the droplets formed on the master mold, and then separating them on the master mold to form micro particles having an encoder pattern formed on a bottom surface thereof. (Step 4).
- a sacrificial layer may be separately formed therebetween to separate the cured droplets on the master mold.
- micro particles having a final encoder pattern corresponding to the negative encoder pattern are formed on the bottom surface.
- the encoder pattern according to an embodiment is generated by a mask patterning process, precision (5 ⁇ m or less) of the encoder pattern is guaranteed, and more than 10 9 encodings are possible. There is an advantage that it is possible to detect a variety of information about the ultra-fine sample.
- the bottom surface may have a three-dimensional shape with a flat shape.
- the microparticles may be hemispherical or semi-elliptic.
- the encoder pattern by the master mold may be imprinted.
- the detector for the labeling substance is always used in a direction perpendicular to the microparticles, it is possible to ensure the accuracy of the detection information and to detect the high sensitivity even when using a very small amount of sample. To improve the reproducibility of the experiment.
- microparticles for bioassay in a simpler and more economical manner than in the prior art by using a mask patterning process and a spotting and imprinting process.
- the microparticles according to the embodiment of the present invention are not separated from the probe region and the encoder region, and thus, real-time PCR can be applied, so that the reaction in the exponential phase can be confirmed in real time with a monitor. The amount of can be accurately quantified.
- An embodiment of the present invention may further include forming an array of an opaque metal layer or a photoresist layer on the encoder pattern of the microparticles of the fourth step.
- detection of bioassay information in various manners is possible, not only the detection information by fluorescence can be obtained, but also the detection information by a general bright field can be easily obtained.
- the photoresist layer may include an epoxy-based negative photoresist, for example, SU-8.
- the metal layer may include at least one of a conductive metal and a conductive polymer.
- the metal layer may include a magnetic material.
- the magnetic material may include, for example, one or more of iron, nickel, cobalt, dynabeads, and bacterial magnetic particles.
- the roughness processing may be further performed on the encoder pattern of the microparticles of the fourth step, so that light scattering occurs more easily during the detection of fluorescence, so that more accurate information may be detected. have.
- One embodiment of the present invention may further comprise the step of further forming pores in the microparticles of the fourth step. If more pores are formed, not only the surface of the microparticles is used for amplification and detection, but also the inside can be used to maximize the reactivity.
- the method for forming pores in the microparticles may include mixing a porogen with a solution for the bioassay and removing the pore copolymer after curing the droplets.
- the pore copolymer may be polyethylene glycol (PEG), and the pore may include a fluorescent marker that provides quantitative information of the nucleic acid to be amplified.
- PEG polyethylene glycol
- a solution for bioassay different from the bioassay of step (c) is spotted on the first droplet and then placed therein. And forming a second droplet to include the first droplet (step (d)).
- the method may be useful when simultaneously detecting information on the type, size, or amount of two or more types of target nucleic acids or fixed primers reacting with one microparticle.
- the label material may be different between the first droplet and the second droplet, an encoder pattern may be formed only on the first droplet, or different encoder patterns may be formed on the first droplet and the second droplet, respectively. If necessary, the third droplet can be implemented.
- the method of reading the encoder pattern of the microparticles manufactured as described above, that is, reading the information of the encoder is not limited, but a CCD camera or the like may be used as an embodiment.
- the information of the encoder may be read individually for each microparticle, or the encoder information of each of the plurality of microparticles arranged in the array may be simultaneously read.
- one embodiment of the present invention is a bio-test material, such as primers, target nucleic acid and the like in the solution and the microparticles according to an embodiment of the present invention after the bio assay, and arranged in an array (array)
- the present invention may provide a method of analyzing a bioassay result by reading an encoder pattern included in each micro particle.
- the microparticles arranged in the array are bioassayed, and the encoder pattern included in each microparticle. It can provide a method of analyzing the bioassay results by reading the.
- SU-8 resin (SU-8 3025, Microchem Co., Ltd.) was poured as a photoresist on a silicon substrate and coated under conditions of 500 rpm for 10 seconds and 200 rpm for 30 seconds.
- An imprint resin layer was formed on the first mold on which the relief encoder pattern was formed.
- the imprint resin a pre-polymer in which a polydimethylsiloxane (PDMS) solution and a curing agent (trade name: SYLGARD® 184, manufactured by Dow Hitech Silicon) in a 10: 1 mixture was poured onto the first mold.
- PDMS polydimethylsiloxane
- SYLGARD® 184 manufactured by Dow Hitech Silicon
- the gas was removed from the vacuum chamber for 60 minutes, then cured in an oven at 80 ° C. for 90 minutes, and separated from the first mold to prepare a master mold having a negative encoder pattern made of PDMS.
- the droplets were formed by spotting a solution for bioassay on the negative encoder pattern formed on the master molder.
- the solution for bioassay was 20% by volume PEG700DA (manufactured by Sigma Aldrich), 40% by volume polyethylene glycol 600 (PEG 600), 5% by volume Darocur 1173 (manufactured by Sigma Aldrich), 0.15% by volume as a photoinitiator. 35 volumes of 3X TE buffer containing tween-20 was used. Then, 5% by volume of EtBr (Interchelator binding to double-stranded nucleic acid and fluorescence with amplification) was further mixed with respect to the total volume of the bioassay solution.
- PEG700DA manufactured by Sigma Aldrich
- PEG 600 polyethylene glycol 600
- Darocur 1173 manufactured by Sigma Aldrich
- the bioassay solution was spotted only on the negative encoder pattern region formed in the master molder by adjusting the open time of the spotting device to form droplets including the negative encoder pattern region therein.
- the droplets are cured by irradiation with ultraviolet (UV) light for 6 minutes at 6 to 8 mW / cm 2 , and then released on the master molder to release the microparticles having an encoder pattern formed on the bottom surface thereof. Formed.
- UV ultraviolet
- Figure 2 shows a side photograph of the droplet formed on the master mold prepared according to an embodiment of the present invention, it can be seen that the shape of the droplet by spotting shows a flat hemispherical bottom surface.
- Figure 3 (a) shows a photograph of a master mold manufactured according to an embodiment of the present invention.
- Figure 3 (b), (c) shows a photograph of the droplet formed by spotting the solution for bio assay on the master mold.
- Figure 3 (d) shows a photograph of the microparticles prepared by curing the droplets, separating the droplets from the master mold.
- 3 (a) to (c) it was confirmed that a high-precision encoder pattern was formed by a mask patterning process and an imprinting process.
- Figure 4 shows a photograph of the microparticles formed with various encoder patterns, according to one embodiment of the present invention.
- the microparticles were formed in a hemispherical shape with a flat bottom surface, so that it was possible to read encoder patterns of all microparticles in a vertically upward direction of the microparticles.
- Figure 5 is a bright field (BF) image (a) after PCR for the microparticles according to an embodiment of the present invention. This was taken with a CCD camera, and it was confirmed that the encoder pattern could be read.
- BF bright field
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Clinical Laboratory Science (AREA)
- Genetics & Genomics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne une microparticule pour un essai biologique et un procédé de fabrication de celle-ci, utilisant des procédés de formation de motif par masque, de repérage et d'impression, l'essai biologique présentant une zone de sonde et une zone de codage, qui ne sont pas séparées et qui se chevauchent, formées dans le même substrat. Selon la présente invention, une PCR en temps réel peut être appliquée et une quantification et une reconnaissance précises en ce qui concerne l'analyse d'informations génétiques est ainsi possible.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2015-0023482 | 2015-02-16 | ||
KR1020150023482A KR101758145B1 (ko) | 2015-02-16 | 2015-02-16 | 바이오 어세이를 위한 마이크로 입자의 제조방법 및 이에 의해 제조된 바이오 어세이를 위한 마이크로 입자 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016133321A1 true WO2016133321A1 (fr) | 2016-08-25 |
Family
ID=56692200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2016/001493 WO2016133321A1 (fr) | 2015-02-16 | 2016-02-15 | Microparticule pour essai biologique et son procédé de fabrication |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101758145B1 (fr) |
WO (1) | WO2016133321A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102088877B1 (ko) * | 2017-07-04 | 2020-03-13 | 한국과학기술연구원 | Ucst 소재를 적용한 입자 및 이를 이용한 핵산 증폭 방법 |
KR102031825B1 (ko) * | 2018-03-07 | 2019-10-15 | 한국과학기술원 | 용액재료의 자발적 상분리와 선택적 젖음을 이용한 미세패턴 제조방법 |
KR102052853B1 (ko) | 2019-05-20 | 2020-01-08 | 주식회사 바이오루츠 | 핵산서열 검출 방법, 다중 핵산마커 검출 방법 및 이를 위한 키트 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137059A1 (en) * | 2001-01-26 | 2002-09-26 | Lei Wu | Microdevice containing photorecognizable coding patterns and methods of using and producing the same thereof |
JP2009174954A (ja) * | 2008-01-23 | 2009-08-06 | Fujitsu Ltd | コード化粒子 |
KR20110133843A (ko) * | 2010-06-07 | 2011-12-14 | 충남대학교산학협력단 | 복제몰딩에 의한 dna-컨쥬게이티드 하이드로겔 마이크로입자의 제조 방법 및 이를 이용한 핵산의 혼성화 분석 방법 |
KR20130021068A (ko) * | 2011-08-22 | 2013-03-05 | 충남대학교산학협력단 | 면역분석용 마이크로 입자 및 이를 사용한 면역분석 방법 |
KR20130082495A (ko) * | 2010-06-07 | 2013-07-19 | 파이어플라이 바이오웍스, 인코포레이티드 | 후혼성 표지화 및 범용 코드화에 의한 핵산 검출 및 정량화 |
KR20140063480A (ko) * | 2012-11-16 | 2014-05-27 | 서울대학교산학협력단 | 코드화된 고분자 미세입자 |
-
2015
- 2015-02-16 KR KR1020150023482A patent/KR101758145B1/ko active IP Right Grant
-
2016
- 2016-02-15 WO PCT/KR2016/001493 patent/WO2016133321A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137059A1 (en) * | 2001-01-26 | 2002-09-26 | Lei Wu | Microdevice containing photorecognizable coding patterns and methods of using and producing the same thereof |
JP2009174954A (ja) * | 2008-01-23 | 2009-08-06 | Fujitsu Ltd | コード化粒子 |
KR20110133843A (ko) * | 2010-06-07 | 2011-12-14 | 충남대학교산학협력단 | 복제몰딩에 의한 dna-컨쥬게이티드 하이드로겔 마이크로입자의 제조 방법 및 이를 이용한 핵산의 혼성화 분석 방법 |
KR20130082495A (ko) * | 2010-06-07 | 2013-07-19 | 파이어플라이 바이오웍스, 인코포레이티드 | 후혼성 표지화 및 범용 코드화에 의한 핵산 검출 및 정량화 |
KR20130021068A (ko) * | 2011-08-22 | 2013-03-05 | 충남대학교산학협력단 | 면역분석용 마이크로 입자 및 이를 사용한 면역분석 방법 |
KR20140063480A (ko) * | 2012-11-16 | 2014-05-27 | 서울대학교산학협력단 | 코드화된 고분자 미세입자 |
Also Published As
Publication number | Publication date |
---|---|
KR20160100689A (ko) | 2016-08-24 |
KR101758145B1 (ko) | 2017-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6440645B1 (en) | Production of microstructures for use in assays | |
US6451191B1 (en) | Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same | |
US20100167950A1 (en) | Microarray chip and method of fabricating for the same | |
CN102449164B (zh) | 从分子阵列制备复制物或衍生物的装置和方法、及其应用 | |
WO2009128938A1 (fr) | Concentration hydrodynamique pour analyser des microbilles rectangulaires | |
EP3336170B1 (fr) | Puce et son application | |
WO2016133321A1 (fr) | Microparticule pour essai biologique et son procédé de fabrication | |
CN101709261A (zh) | 一种微流控微珠阵列芯片及其在病毒分析中的应用 | |
US20130210646A1 (en) | Hemomosaic: high-throughput technique for rare cell detection in liquid samples by massively multiplexed pcr in a photolithographic matrix | |
US10174313B2 (en) | Methods and devices for micro-isolation, extraction, and/or analysis of microscale components in an array | |
Fang | Microfluidic chip | |
Yue et al. | Single layer linear array of microbeads for multiplexed analysis of DNA and proteins | |
WO2017069587A1 (fr) | Procédé d'analyse sélective d'échantillon biologique | |
US20070140912A1 (en) | Fiber optic interrogated microfluidic device | |
JP2008304440A (ja) | ビーズ群と該ビーズ群の作製方法、並びにビーズ群を用いる方法 | |
CN111250177B (zh) | 一种生物分子检测方法 | |
WO2022045806A1 (fr) | Fabrication d'appareil de surveillance d'un organoïde en temps réel à l'aide d'un procédé r2r | |
CN113687062A (zh) | 基于虚拟分割方法的生物靶标数字化定量芯片检测方法 | |
KR101530932B1 (ko) | 패턴이 입력된 인코더를 포함하는 바이오 어세이용 마이크로 구조체 | |
KR100719029B1 (ko) | 마이크로-웰 플레이트 | |
Rabiee et al. | Microarray technologies | |
Orcheston-Findlay et al. | PVP treatment of PS/PtOEPK sensor films for improved adherence of cancer cells | |
WO2018093156A2 (fr) | Structure de substrat comprenant des particules hétérogènes | |
QINGDI | Microparticle Array on Gel Microstructure Chip for Multiplexed Biochemical Assays | |
JP2005030927A (ja) | 生体関連分子マイクロアレイ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16752651 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16752651 Country of ref document: EP Kind code of ref document: A1 |